Search results
Merck’s trial of KEYTRUDA regimen fails to meet primary endpoint
Clinical Trials Arena via Yahoo Finance· 4 days agoEarlier this month, Merck reported the final analysis findings from the Phase III KEYNOTE-811 trial...
IDEAYA Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
WKBN 27 Youngstown· 7 days agocancer targeted mid-year 2024Targeting initial Phase 2 expansion for IDE161 in HRD solid tumors and Phase 1 FPI for IDE161 in combination with Merck's anti-PD-1 therapy < ...
Bristol Myers (BMY) Fails to Meet Goal in Opdivo NSCLC Study
Zacks· 1 day agoFree Report) recently announced that a late-stage study, seeking to expand the label of its cancer combination drug, Opdivo (nivolumab) and Yervoy (ipilimumab ...
Merck's endometrial cancer therapy fails trial
Reuters via Yahoo News· 5 days agoThe drugmaker's Keytruda therapy in combination with chemotherapy was being evaluated in about 1,095 patients with high-risk endometrial cancer after...
...Results From an In Vitro Binding Study of Its Hemopurifier® in Removing Extracellular Vesicles...
The Record Gazette· 4 days agoAethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today announced ...
Aethlon Medical Stock Surges In Pre-market On Positive Hemopurifier Trial Results
RTT News· 4 days agoIn pre-market activity on the Nasdaq, Aethlon shares were surging more than 101 percent to trade at $2.44. The company...clinical trials of the Hemopurifier in patients with solid tumors who ...
Calliditas' survival data salvage midphase cancer trial after primary endpoint miss
FierceBiotech· 7 days agoCalliditas Therapeutics had a typical to-do list for its midphase head and neck cancer study. Step...
The doctor behind the next big thing in cancer treatment
CNN via Yahoo News· 5 days agoDr Catherine Wu’s research has laid the scientific foundation for the development of cancer vaccines...
Merck's endometrial cancer therapy fails trial
AOL· 5 days agoThe drugmaker's Keytruda therapy in combination with chemotherapy was being evaluated in about 1,095 patients with high-risk endometrial cancer after surgery ...
Cancer Vaccines' Emergence; More Focus on Side Effects; A Nudge for Exercise
MedPage Today· 4 days agoNews, features, and commentary about cancer-related issues